Related references
Note: Only part of the references are listed.The gene expression profile of phosphoantigen-specific human ?d T lymphocytes is a blend of a ss T-cell and NK-cell signatures
Frederic Pont et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
CD70 expression patterns in renal cell carcinoma
Lucia B. Jilaveanu et al.
HUMAN PATHOLOGY (2012)
Human Vγ9Vδ2 T Cells Specifically Recognize and Kill Acute Myeloid Leukemic Blasts
Julie Gertner-Dardenne et al.
JOURNAL OF IMMUNOLOGY (2012)
Tumor-promoting Versus Tumor-antagonizing Roles of γδ T Cells in Cancer Immunotherapy: Results From a Prospective Phase I/II Trial
Volker Kunzmann et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Harnessing γδ T cells in anticancer immunotherapy
Dalil Hannani et al.
TRENDS IN IMMUNOLOGY (2012)
Clinical evaluation of autologous gamma delta T cell-based immunotherapy for metastatic solid tumours
A. J. Nicol et al.
BRITISH JOURNAL OF CANCER (2011)
Combined Genetic Inactivation of β2-Microglobulin and CD58 Reveals Frequent Escape from Immune Recognition in Diffuse Large B Cell Lymphoma
Madhavi Challa-Malladi et al.
CANCER CELL (2011)
Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma
Joshua M. Lang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
How tumors might withstand γδ T-cell attack
Aude-Helene Capietto et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Interindividual Variability of Response to Rituximab: From Biological Origins to Individualized Therapies
Guillaume Cartron et al.
CLINICAL CANCER RESEARCH (2011)
Zoledronate-activated V gamma 9 gamma delta T cell-based immunotherapy is feasible and restores the impairment of gamma delta T cells in patients with solid tumors
Atsutaka Noguchi et al.
CYTOTHERAPY (2011)
Stimulated γδ T Cells Increase the In Vivo Efficacy of Trastuzumab in HER-2+ Breast Cancer
Aude-Helene Capietto et al.
JOURNAL OF IMMUNOLOGY (2011)
Adjuvant zoledronic acid for breast cancer: mechanism of action?
Volker Kunzmann et al.
LANCET ONCOLOGY (2011)
Immune parameters affecting the efficacy of chemotherapeutic regimens
Laurence Zitvogel et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
PGE2 inhibits natural killer and γδ T cell cytotoxicity triggered by NKR and TCR through a cAMP-mediated PKA type I-dependent signaling
Ludovic Martinet et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vγ9Vδ2 T lymphocyte agonist in patients with solid tumors
Jaafar Bennouna et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Optimizing Tumor-Reactive γδ T Cells for Antibody-Based Cancer Immunotherapy
S. Meraviglia et al.
CURRENT MOLECULAR MEDICINE (2010)
A phase I study of adoptive immunotherapy for recurrent non-small-cell lung cancer patients with autologous γδ T cells
Jun Nakajima et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2010)
Phosphoantigens Overcome Human TCRVγ9+ γδ Cell Immunosuppression by TGF-β: Relevance for Cancer Immunotherapy
Aude-Helene Capietto et al.
JOURNAL OF IMMUNOLOGY (2010)
Vγ9Vγ2 T Lymphocytes Efficiently Recognize and Kill Zoledronate-Sensitized, Imatinib-Sensitive, and Imatinib-Resistant Chronic Myelogenous Leukemia Cells
Matilde D'Asaro et al.
JOURNAL OF IMMUNOLOGY (2010)
Zoledronate Stimulates gamma delta T Cells in Prostate Cancer Patients
Michio Naoe et al.
ONCOLOGY RESEARCH (2010)
γδ T cell effector functions: a blend of innate programming and acquired plasticity
Marc Bonneville et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Phosphoantigen-activated Vγ2Vδ2 T cells antagonize IL-2-induced CD4+CD25+Foxp3+ T regulatory cells in mycobacterial infection
Guangming Gong et al.
BLOOD (2009)
Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies
Julie Gertner-Dardenne et al.
BLOOD (2009)
Intravesical administration of gamma delta T cells successfully prevents the growth of bladder cancer in the murine model
Takeshi Yuasa et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Antitumor Activity of γδ T Cells Reactive against Cytomegalovirus-Infected Cells in a Mouse Xenograft Tumor Model
Christel Devaud et al.
CANCER RESEARCH (2009)
A regulatory cross-talk between Vγ9Vδ2 T lymphocytes and mesenchymal stem cells
Ludovic Martinet et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Clinical and immunological evaluation of zoledronate-activated Vγ9γδ T-cell-based immunotherapy for patients with multiple myeloma
Yu Abe et al.
EXPERIMENTAL HEMATOLOGY (2009)
gamma delta T cells as immune effectors against high-grade gliomas
Lawrence S. Lamb
IMMUNOLOGIC RESEARCH (2009)
Inhibition of phosphoantigen-mediated γδ T-cell proliferation by CD4+ CD25+ FoxP3+ regulatory T cells
Volker Kunzmann et al.
IMMUNOLOGY (2009)
Pitfalls on the roadmap to γδ T cell-based cancer immunotherapies
Ludovic Martinet et al.
IMMUNOLOGY LETTERS (2009)
Large scale expansion of Vγ9Vδ2 T lymphocytes from human peripheral blood mononuclear cells after a positive selection using MACS TCR γ/δ + T cell isolation kit
Samuel Salot et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2009)
Cutting Edge: TGF-β1 and IL-15 Induce FOXP3+ γδ Regulatory T Cells in the Presence of Antigen Stimulation
Rita Casetti et al.
JOURNAL OF IMMUNOLOGY (2009)
Characterization and immunotherapeutic potential of γδ T-cells in patients with glioblastoma
Nichole L. Bryant et al.
NEURO-ONCOLOGY (2009)
Phase-I study of Innacell γδ™, an autologous cell-therapy product highly enriched in γ9δ2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma
Jaafar Bennouna et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Zoledronate facilitates large-scale ex vivo expansion of functional gamma delta T cells from cancer patients for use in adoptive immunotherapy
M. Kondo et al.
CYTOTHERAPY (2008)
Questionable relevance of γδ T lymphocytes in renal cell carcinoma
Brant A. Inman et al.
JOURNAL OF IMMUNOLOGY (2008)
Chemokine receptors expression and migration potential of tumor-infiltrating and peripheral-expanded Vγ9Vδ2 T cells from renal cell carcinoma patients
Emilie Viey et al.
JOURNAL OF IMMUNOTHERAPY (2008)
In vitro expansion of gamma delta T cells with anti-myeloma cell activity by Phosphostim and IL-2 in patients with multiple myeloma
Maka Burjanadze et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Tumor-infiltrating γδ T cells suppress T and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway
Guangyong Peng et al.
IMMUNITY (2007)
Targeting human γδ T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer
Francesco Dieli et al.
CANCER RESEARCH (2007)
Safety profile and anti-tumor effects of adoptive immunotherapy using gamma-delta T cells against advanced renal cell carcinoma: a pilot study
Hirohito Kobayashi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
A tuberculosis vaccine based on phosphoantigens and fusion proteins induces distinct γδ and αβ T cell responses in primates
Delphine Cendron et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Immune escape for renal cell carcinoma: CD70 mediates apoptosis in lymphocytes
Julia Diegmann et al.
NEOPLASIA (2006)
GM2 expression in renal cell carcinoma: Potential role in tumor-induced T-cell dysfunction
Kaushik Biswas et al.
CANCER RESEARCH (2006)
Peripheral γδ T-lymphocytes as an innovative tool in immunotherapy for metastatic renal cell carcinoma
Emilie Viey et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2005)
Vγ9Vδ2 T cell response to colon carcinoma cells
M Corvaisier et al.
JOURNAL OF IMMUNOLOGY (2005)
Statins prevent bisphosphonate-induced γ,δ-T-cell proliferation and activation in vitro
K Thompson et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Potential of human γδ T lymphocytes for immunotherapy of cancer
D Kabelitz et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Induction of γδ T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo
F Dieli et al.
BLOOD (2003)
γδ T cells for immune therapy of patients with lymphoid malignancies
M Wilhelm et al.
BLOOD (2003)
Inhibition of tumor rejection by γδ T cells and IL-10
Y Ke et al.
CELLULAR IMMUNOLOGY (2003)
Peripheral γδ T-cell deficit in nasopharyngeal carcinoma
BJ Zheng et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene
G Cartron et al.
BLOOD (2002)
Anti-tumor effects of human peripheral γδ T cells in a mouse tumor model
BJ Zheng et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Share Paper
